Group 1: Healthcare Policy Changes - The new national medical insurance drug list has been implemented, adding 114 new drugs covering areas such as cancer, diabetes, and rare diseases [2] - A new batch of centralized procurement for 55 drugs will take place in February 2026, including medications for allergies, diabetes, and antiviral treatments [2] - The National Health Commission mandates that primary healthcare institutions must be equipped with at least five categories of antihypertensive drugs starting March 1, 2026 [3] Group 2: Maternal and Child Health Initiatives - From July 1, 2025, Jiangsu Province has implemented a "zero out-of-pocket" policy for hospital deliveries, with the aim to expand this benefit nationwide by 2026 [4] - The 2026 initiatives include increasing maternity subsidies, expanding coverage for flexible workers and migrant workers, and integrating suitable pain relief methods into medical insurance [4] Group 3: Long-term Care Insurance Developments - Long-term care insurance is currently focused on severely disabled individuals, with plans to include moderately disabled individuals by 2026 [6] - An action plan to enhance elderly care services will be launched, establishing geriatric departments in hospitals and extending care services to communities and homes [6] Group 4: Medical Service Accessibility and Efficiency - The medical imaging cloud platform will expand its cross-province data sharing capabilities, aiming for over 300 mutual recognition projects among medical institutions by the end of 2027 [8] - Starting January 1, 2026, all medical institutions must implement full collection and upload of drug traceability codes to combat illegal use of medical insurance funds [8]

Group 1 - The core viewpoint of the article highlights the implementation of new healthcare policies in 2026 that will benefit the public, including the introduction of new drugs and medical services [2] - A total of 114 new drugs will be included in the national medical insurance drug list, covering areas such as cancer, diabetes, and rare diseases, with an additional 19 innovative drugs for commercial insurance [3] - The latest batch of centralized procurement for 55 drugs will take place in February 2026, including medications for allergies, diabetes, and antiviral treatments [3] Group 2 - From March 1, 2026, primary healthcare institutions are required to stock at least five categories of antihypertensive drugs to enhance medication accessibility [4] - The "zero out-of-pocket" policy for hospitalization during childbirth will expand nationwide, aiming for full coverage of eligible expenses by 2026 [5] - The long-term care insurance (LTCI) will transition from pilot programs to comprehensive coverage for all insured individuals, enhancing elderly care services [8] Group 3 - The medical insurance imaging cloud will facilitate the sharing of diagnostic imaging data, reducing the need for patients to carry physical records and minimizing repeated tests [9] - By 2026, the cross-province sharing of medical insurance accounts will be fully implemented, along with advancements in payment methods to reduce hospital wait times [11] - All medical institutions will be required to upload drug traceability codes starting January 1, 2026, to combat illegal activities related to medical insurance funds [11]